Stereotactic psychosurgery (cingulotomy, capsulotomy, gamma knife)

1. Introduction

Version followed: current ablative neurosurgery for mental disorder (NMD) as described in the international consensus guidelines of the world, European, American, Latin American and Asian-Australasian stereotactic neurosurgery societies and the World Psychiatric Association (Nuttin et al., 2014), with UK practice as described by Whitehead and Barrera (2023), gamma-knife capsulotomy as reviewed by Miguel et al. (2019), complications as reviewed by Mavridis and Pyrgelis (2025), and the legal rules of England and Wales, Scotland, Victoria (Australia) and California as the sources state them. Status checked October 2026.

This is not a psychotherapy. It is irreversible brain surgery decided and delivered by a multidisciplinary specialist team (stereotactic and functional neurosurgeons, psychiatrists, neurologists, neuropsychologists), for a very small number of people with severe, chronic, disabling obsessive-compulsive disorder (OCD) or depression that has not responded to adequate trials of medication, cognitive-behavioural therapy (CBT, including exposure and response prevention, ERP, for OCD) and, for depression, usually electroconvulsive therapy [source: Nuttin 2014; Whitehead & Barrera 2023]. The procedures named in this entry make a small, permanent lesion in a named brain region: anterior cingulotomy (the anterior cingulate region), anterior capsulotomy (the anterior limb of the internal capsule), made either by heat through a probe (radiofrequency/thermal), by focused radiation without opening the skull (gamma-knife capsulotomy, including the "gamma ventral capsulotomy" variant), or, most recently, by MRI-guided focused ultrasound [source: Mavridis & Pyrgelis 2025; Miguel 2019]. This guide gives no technique, targeting, lesion or radiation details.

Core idea of how change happens, as the sources frame it: the lesion is intended to interrupt circuits linking frontal cortex and deeper structures that are thought to sustain the illness; it treats symptoms rather than curing the illness, and is "only one part" of a longer treatment plan that continues after surgery, including medication and psychological therapy [source: Nuttin 2014; Whitehead & Barrera 2023 notes medication is still needed]. Miguel et al. (2019) suggest that part of the improvement after gamma capsulotomy may reflect a better response to medication and psychological therapy afterwards [source: Miguel 2019]. Improvement is often gradual, sometimes continuing for 6 to 36 months [source: Miguel 2019].

Current status (as of October 2026, per the sources):

UK: Dundee (Scotland) is described as the only UK centre regularly performing anterior cingulotomy; Dundee moved from capsulotomy to cingulotomy after reports of side effects; seven capsulotomies were approved at the University Hospital of Wales, Cardiff, between 2005 and 2009 [source: Whitehead & Barrera 2023]. Scotland's 1996 review concluded NMD should remain available only for intractable OCD and affective disorders [source: Whitehead & Barrera 2023]. Whether Cardiff still operates was not confirmed [uncertain].
Gamma-knife capsulotomy for OCD has been developed at the Karolinska Institute (Sweden), by a Providence (Brown University/Butler Hospital) group in the US, and by a São Paulo (Brazil) group that ran a double-blind sham-controlled trial [source: Miguel 2019].
Victoria (Australia) keeps a legal pathway for "neurosurgery for mental illness", mostly for severe depression and OCD [source: Health Victoria].
Evidence status: the consensus guideline describes ablative procedures as "established" in some countries for depression and OCD with level II (not level I, randomised) evidence, and sets as a standard for an approved therapy at least two blinded randomised trials from different groups [source: Nuttin 2014]. Deep brain stimulation (DBS), the reversible alternative, is described as still investigational for every psychiatric indication [source: Nuttin 2014]. No medicines/device regulator (FDA, MHRA, EMA) labelling is described for these lesion procedures as psychiatric treatments; their control is through mental health law, ethics review and specialist panels [uncertain].
Other indications (anxiety, anorexia nervosa, schizophrenia, aggression, Tourette syndrome) appear only in case reports and small series [source: Mavridis & Pyrgelis 2025]; the consensus guideline bars surgery for political, law-enforcement or social purposes [source: Nuttin 2014].

The full history of lobotomy and its harms is in Domain XVI; a short harm account appears at the end of this guide.

2. Framework

The pathway below is assembled from the consensus guideline and legal sources; the sequencing and the psychotherapist's tasks are [synthesis].

Treatment-refractory phase (before any referral). Goal: make sure every reasonable, less invasive, evidence-based option has been tried at adequate dose and duration: medicines, CBT (ERP for OCD) and ECT where relevant [source: Nuttin 2014]. One gamma-capsulotomy study required at least 20 sessions of CBT with ERP without lasting improvement before surgery [source: Copetti et al. 2020]. Move on only when the treating psychiatrist documents refractoriness and little hope of spontaneous recovery [source: Nuttin 2014]. Psychotherapist: check whether therapy was truly adequate (an expert ERP trial, not generic counselling) [synthesis].
Referral and independent assessment. Goal: independent psychiatric experts assess severity, chronicity, disability and treatment resistance with standardised scales; suicide risk is assessed; a full neuropsychological evaluation covers cognition, personality, psychiatric status, goals and expectations, adherence and family/social support [source: Nuttin 2014]. Decision: the multidisciplinary team must agree unanimously; if not, no one acts alone and outside opinion is sought [source: Nuttin 2014]. Timescale: months [uncertain: not stated in sources].
Consent, capacity and legal certification. Goal: free, informed, sustained consent from a person with capacity, checked repeatedly; then the statutory or tribunal process for the jurisdiction (see 4A.2) [source: Nuttin 2014; MHA 1983 s57; MH(CT)(S)A 2003 ss234-236; Health Victoria; California W&I Code]. Surgery cannot proceed until certificates or approval are in place.
Surgery and early recovery. Delivered by the neurosurgical team; short-term effects such as incontinence, sleep problems, fatigue and disorientation usually settle within weeks after thermal capsulotomy [source: Mavridis & Pyrgelis 2025]. Psychotherapist: usually a pause in sessions; keep contact and the crisis plan active [synthesis].
Rehabilitation and integration (roughly months 1-36). Goal: rebuild function and use any symptom reduction; continue medication as prescribed and resume or begin psychological therapy (ERP for OCD) [source: Nuttin 2014 on continuing treatment; Miguel 2019 on possible synergy; timing of ERP is synthesis]. Response may be delayed and gradual [source: Miguel 2019].
Long-term follow-up (at least 5-10 years). Goal: repeated neurological, psychiatric and neuropsychological review; recording all side effects including personality change; non-abandonment until care is formally transferred; ongoing support for social readjustment [source: Nuttin 2014]. In Victoria, written outcome reports are due to the Chief Psychiatrist within three months and again 9-12 months after surgery [source: Health Victoria].

Format: the surgical team's assessments are clinic- and hospital-based; the psychotherapist's work is ordinary individual (and family) sessions running alongside, with written communication to the team at each phase change [synthesis].

3. Guiding principles

Last resort, never first or convenient resort - Practical meaning: you never raise surgery as an option to someone who has not had expert ERP/CBT and the other standard treatments; you help document what has been tried [source: Nuttin 2014; Whitehead & Barrera 2023].
Irreversibility drives everything - Practical meaning: every conversation about it states plainly that the lesion cannot be undone, unlike DBS [source: Mavridis & Pyrgelis 2025; Whitehead & Barrera 2023].
Treatment of the individual, for the individual - Practical meaning: any hint that surgery is being sought to manage behaviour, satisfy a family, an institution or the courts is a stop signal [source: Nuttin 2014, citing the 1977 US National Commission report].
Free, informed, sustained consent from a person with capacity - Practical meaning: you watch for pressure (including the person's own desperation) and for capacity changing with mood [source: Nuttin 2014].
No single decision-maker - Practical meaning: decisions come from a unanimous multidisciplinary team plus independent legal certification; you are a contributor of information, not a gatekeeper or advocate for surgery [source: Nuttin 2014; MHA 1983 s57].
Surgery is one step in a longer treatment - Practical meaning: plan the post-operative psychological work before the operation [source: Nuttin 2014; synthesis on planning].
Realistic expectations - Practical meaning: roughly half to two-thirds respond at experienced centres for OCD gamma capsulotomy and around half for capsulotomy in depression in one series; some get worse; benefit may take a year or more [source: Miguel 2019; Whitehead & Barrera 2023].
Complete, honest monitoring - Practical meaning: you report changes, including bad outcomes and personality change, to the team; the guideline asks teams to report all outcomes [source: Nuttin 2014].
Non-abandonment - Practical meaning: you stay in the person's care network for years, or hand over formally [source: Nuttin 2014].
Disclosure of interests - Practical meaning: patients should be told about researchers' and clinicians' conflicts of interest; you can help the person ask [source: Nuttin 2014].
Stay within your role - Practical meaning: never advise for or against the operation or on medicines; route clinical questions to the team and prescriber [synthesis].

4. Intervention inventory

Part A describes how the specialist team and the law deliver the treatment, at a descriptive level only. Part B is the psychotherapist's own work alongside them.

A1. The procedures and what is reported about them (descriptive)

Purpose: so you can explain, in plain terms and accurately, what the person is being offered, and recognise expected and worrying changes afterwards.
What is delivered: a permanent lesion in a named region, made by (a) radiofrequency/thermal probe (oldest, cheapest, used since the 1950s), (b) gamma-knife radiosurgery, which needs no incision, or (c) MRI-guided focused ultrasound, newest and least available [source: Mavridis & Pyrgelis 2025]. Cingulotomy is sometimes combined with capsulotomy [source: Mavridis & Pyrgelis 2025].
Reported outcomes, OCD: anterior capsulotomy, a meta-analysis of 5 studies (50 patients), about 54% full response; anterior cingulotomy (34 patients), average symptom reduction about 36%, with 83% of early responders keeping at least partial response at about 5 years [source: Whitehead & Barrera 2023]. Gamma capsulotomy: favourable responses in about one-half to two-thirds at experienced centres; in a 16-patient double-blind sham-controlled trial the 12-month difference in responders (2/8 vs 0/8) was not statistically significant, though symptom scores favoured surgery, and 7 of 12 were full responders in open follow-up [source: Miguel 2019]. More obsessive-compulsive personality symptoms at baseline predicted a smaller response in a 14-patient study [source: Copetti 2020].
Reported outcomes, depression: capsulotomy in Dundee (20 patients, mean follow-up 7 years) 50% responders and 10% worse; cingulotomy (8 patients, 12 months) 2 responders and 3 remissions [source: Whitehead & Barrera 2023].
Reported adverse effects: thermal capsulotomy: short-term urinary incontinence, sleep problems, fatigue, disorientation, usually settling within weeks; also reported seizures, weight gain, frontal-lobe-type apathy and executive problems; in older series memory loss, personality change, reduced motivation, bulimia and increased sexual interest [source: Mavridis & Pyrgelis 2025]. Across capsulotomy OCD studies 21.4% had serious or permanent effects; one study found executive dysfunction, apathy or disinhibition in seven patients; treated patients recognised emotions in video clips less well than healthy controls [source: Whitehead & Barrera 2023]. Gamma knife: mood disturbance was the most common effect (about a quarter in one large series); worsened OCD and neurological problems about 7.5% each; brain swelling with headache, apathy, fatigue, loss of initiative and disinhibition in early cohorts; radiation necrosis and cysts (about 5% at long-term follow-up), sometimes appearing years later [source: Mavridis & Pyrgelis 2025; Miguel 2019]. Formal testing has generally not shown overall cognitive decline after cingulotomy or capsulotomy, with possible gains in executive function [source: Whitehead & Barrera 2023; Miguel 2019]. MRgFUS: only mild, short-lived headache and balance symptoms reported in small studies [source: Mavridis & Pyrgelis 2025].
Watch for: late-emerging change (cysts years later after gamma knife), apathy and loss of initiative, disinhibition, mood disturbance, worsening symptoms, weight and eating change, seizures [source: as above]. Always pass these to the team; do not interpret them yourself [synthesis].
Example language (illustrative): "The surgeons make a small, permanent lesion in a part of the brain linked to OCD or depression. Around half of people in published series improve, often slowly, and some get worse; your team will give you their own figures." [synthesis]

A2. Legal and ethical safeguards, by jurisdiction (as the sources state them)

Purpose: so you can tell the person and family what independent checks will happen, and recognise a pathway that skips them.
International standard: independent ethics committee or IRB oversight for anything investigational, keeping research and clinical care separate; extra protection for children, military personnel, students and prisoners; bioethics advice in complex cases; surrogate consent only in very rare cases with clear legal authority after every effort to obtain the person's own consent; consent maintained throughout and withdrawable at any time [source: Nuttin 2014].
England and Wales, Mental Health Act 1983 s57: covers any surgical operation destroying brain tissue or its functioning (and surgical hormone implantation to reduce male sexual drive, by regulation). It needs (1) the patient's consent; (2) a certificate from an independent registered medical practitioner appointed by the regulator (not the responsible clinician or the person in charge of treatment) and two other appointed non-doctors that the patient understands the nature, purpose and likely effects and has consented; and (3) a certificate from that doctor that the treatment is appropriate, after consulting two professionals involved in the patient's treatment, one a nurse and one neither a nurse nor a doctor [source: mentalhealthlaw.co.uk s57 text]. There is no route for a patient who lacks capacity [source: Whitehead & Barrera 2023, "capacity to give sustained informed consent"]. That s57 also covers informal patients (via s56) is [uncertain]. The Wales form CO1 (certificate of consent and second opinion) is not drawn on here [uncertain]. Mental health law reform (a Mental Health Act 2025 is referenced on the mentalhealthlaw.co.uk site) may have changed details; check the current Code of Practice [uncertain].
Scotland, Mental Health (Care and Treatment) (Scotland) Act 2003 ss234-236: applies to any patient whether or not detained. Capable patient: a designated medical practitioner certifies capacity, written consent and best interests, and two lay persons appointed by the Mental Welfare Commission certify capacity and written consent (they may interview in private). Incapable patient: cannot be treated if they object or resist; if not objecting, a designated practitioner and two lay persons certify, and the responsible medical officer must obtain an order from the Court of Session, which may authorise only if the treatment is in the person's best interests, likely to alleviate or prevent deterioration, and the person does not object. Under-16s require a child-specialist designated practitioner [source: Explanatory Notes to the 2003 Act].
Victoria, Australia (Mental Health and Wellbeing Act 2022): only the person's own written informed consent counts; no guardian, parent or substitute can consent; the psychiatrist applies to the Mental Health Tribunal, which must decide within 30 business days and may approve only if satisfied of consent and benefit, weighing likely relief, consequences of not operating, alternatives and the person's views, and risks and side effects; outcome reports to the Chief Psychiatrist at 3 and 9-12 months [source: Health Victoria].
California, US: patients have the right to refuse psychosurgery, defined to include operations "currently referred to as lobotomy, psychiatric surgery" [source: W&I Code 5325]. As summarised in a San Mateo County policy citing W&I Code 5326.x: no psychosurgery on a minor under any circumstances; not earlier than 72 hours after written consent; three physicians, two of them psychiatrists or neurosurgeons and none involved in the person's treatment, must examine and unanimously agree on capacity; a relative chosen by the patient is informed with the patient's consent; consent may be withdrawn at any time with immediate effect [source: San Mateo County BHRS Policy 13-01, 2013]. The statute text of 5326.6 itself is [uncertain]. Rules in other US states were not checked [uncertain].
Watch for: any pathway where a family member, guardian, institution or court "consents" for an objecting or incapable person outside these routes; where no independent second opinion or panel is involved; or where surgery is offered outside a recognised centre [source: legal rules above; synthesis on red flags].
Example language (illustrative): "Where you live, the law requires independent doctors or a tribunal to confirm that you understand and agree before this surgery can go ahead. That protection is there for you." [synthesis]

B1. Recognising when a specialist review may be worth raising (and when it is not)

Purpose: to make sure a person with genuinely refractory illness hears about specialist assessment from their psychiatrist, and that no one is steered towards surgery before adequate standard care [source: Nuttin 2014 selection criteria; role framing synthesis].
Steps: (1) Map the treatment history with the client and, with consent, their psychiatrist: medicines tried, ECT, and specifically whether ERP was delivered by a trained therapist with real exposure work and enough sessions (one surgical study required at least 20 ERP sessions without lasting benefit) [source: Copetti 2020]. (2) If ERP was never adequate, recommend an expert ERP or intensive programme first [synthesis]. (3) If standard care truly has failed and disability is severe and long-standing, suggest the client ask their psychiatrist whether a referral to a specialist (neuromodulation/NMD) service for assessment is appropriate; the psychiatrist, not you, refers [synthesis]. (4) Write a short summary of the therapy delivered, dose and response, for the psychiatrist.
Example language (illustrative): "From what you've told me, we haven't yet done a full course of exposure work with someone who specialises in it. I'd want that properly tried before anything more drastic is discussed." / "Your psychiatrist is the right person to say whether a specialist assessment makes sense. Would it help if I wrote down what we've tried in therapy for them?"
Watch for: clients seeking surgery as an escape from exposure work; family pressure; promotion of surgery by a non-specialist or overseas private provider [synthesis].

B2. Psychoeducation and balanced information

Purpose: to help the person and family understand what is known, without persuading either way [source: Nuttin 2014 on understanding risks, benefits and alternatives].
Steps: (1) Explain that it is irreversible, treats symptoms rather than cures, and is one part of continuing treatment [source: Nuttin 2014]. (2) Give realistic ranges from the team's own information, e.g. that around half respond in published series, some worsen, and benefit may take a year or more [source: Whitehead & Barrera 2023; Miguel 2019]. (3) Name the main reported risks in plain words (apathy, disinhibition, mood change, incontinence early on, seizures, weight change; cysts years later with gamma knife) and say the team will give the details for their centre [source: Mavridis & Pyrgelis 2025]. (4) Mention reversible alternatives the team may discuss, such as DBS, which is investigational, costly and has its own risks [source: Whitehead & Barrera 2023; Nuttin 2014]. (5) Encourage written questions for the team, including about outcome data for that centre and any conflicts of interest [source: Nuttin 2014 on disclosure].
Example language (illustrative): "The team will give you their own figures. What I can say is that it doesn't work for everyone, it can't be reversed, and the improvement often comes slowly."
Watch for: magical expectations ("it will switch the OCD off"); confusion with historical lobotomy and resulting terror; you drifting into advocacy [synthesis].

B3. Supporting informed consent, capacity and shared decision-making

Purpose: to support a free, informed and sustained decision; capacity and consent are assessed by the team and statutory second-opinion doctors, not by you [source: Nuttin 2014; MHA 1983 s57; MH(CT)(S)A 2003].
Steps: (1) Explore the person's own reasons, values and fears separately from family members. (2) Use a decision-balance discussion covering staying as they are, other options and surgery [synthesis]. (3) Notice desperation: the guideline warns it can push people into hasty decisions [source: Nuttin 2014]. (4) Notice fluctuating capacity: severe depression or OCD doubt can change understanding over time; tell the team if you see it [source: Nuttin 2014 on rechecking capacity]. (5) Explain the independent checks for their jurisdiction (A2) and that consent can be withdrawn at any point [source: Nuttin 2014; San Mateo policy]. (6) With consent, share relevant observations with the team.
Example language (illustrative): "I'm not here to push you either way. I want to be sure that, whatever you decide, it's your decision and you know what you're deciding." / "You can say no at any stage, including after you've signed something."
Watch for: a decision made to please others, under hopelessness, or during a suicidal crisis; inability to retain or weigh information. Pass concerns on, with consent where possible [synthesis].

B4. Pre-operative baseline and expectation work

Purpose: to give the team and the person a reference point, since outcomes are judged on symptoms, function, quality of life and patient and family views [source: Nuttin 2014].
Steps: (1) With the team's agreement, record your own standardised symptom and function measures before surgery (use the scales the team uses, e.g. the Y-BOCS for OCD, where you are trained; do not reproduce items) [synthesis; Y-BOCS named in Copetti 2020]. (2) Write down with the client concrete, personal goals ("take the bus to work") and what would count as "better". (3) Note baseline personality style, interests, humour, sexuality and eating habits, with family input, so later change can be recognised [synthesis, informed by reported personality/appetite effects in Mavridis & Pyrgelis 2025]. (4) Discuss in advance what happens if surgery does not help.
Example language (illustrative): "Let's write down how things are now, in your words, so in a year we can see clearly what has and hasn't changed."
Watch for: all-or-nothing goals; no plan for non-response [synthesis].

B5. Family and carer involvement

Purpose: family and social support is part of the assessment, social readjustment can be hard, and patients' and families' views are part of outcome assessment [source: Nuttin 2014].
Steps: (1) With consent, offer a joint session to share information and expectations. (2) Separate the person's wishes from the family's, and say so openly. (3) Brief family on early recovery effects and later changes to report (apathy, disinhibition, mood change). (4) Plan how family accommodation of OCD rituals will be reduced as symptoms ease [synthesis].
Example language (illustrative): "It matters that this is your son's choice. What would you notice at home that you'd want the team to hear about?"
Watch for: surrogate pressure; carers who want behaviour controlled rather than suffering relieved - the guideline bars surgery for social purposes [source: Nuttin 2014].

B6. Crisis and safety planning around the surgical period

Purpose: suicide risk must be assessed for all candidates [source: Nuttin 2014]; hope and disappointment around a last-resort treatment can increase risk [synthesis].
Steps: (1) Update a written safety plan before referral, before surgery and after: warning signs, coping steps, people and services to contact, lethal-means counselling (safe storage and removal) [synthesis, standard practice]. (2) Agree who to contact in the surgical team and the local crisis service. (3) Plan extra contact at predictable low points: refusal by a panel, the waiting period, the first months when nothing seems to change, and if the outcome is poor [synthesis]. (4) Share risk information promptly with the team and GP.
Example language (illustrative): "If the panel says no, or the operation doesn't help as much as you hope, that could hit hard. Let's plan now for what you'd do and who you'd call."
Watch for: "this is my last chance" statements; withdrawal after refusal; hopelessness at months 3-12 [synthesis].

B7. Post-operative monitoring and passing on changes

Purpose: to help catch adverse effects early and support the required long-term follow-up [source: Nuttin 2014; adverse effects from Mavridis & Pyrgelis 2025; Miguel 2019].
Steps: (1) Repeat your baseline measures at agreed intervals. (2) Ask routinely about mood, initiative and motivation, impulsivity and disinhibition, appetite and weight, sexual behaviour, memory, headaches, continence, seizures and any new neurological symptoms. (3) Pass any change in writing to the surgical team and psychiatrist; urgent neurological symptoms (fit, severe headache, new weakness) go to urgent medical care [synthesis]. (4) Remember gamma-knife effects can appear years later [source: Mavridis & Pyrgelis 2025].
Example language (illustrative): "Some people notice changes in their energy, drive or how much they hold back. Have you or your family noticed anything like that?"
Watch for: apathy mistaken for "calm" or for depression; family reports differing from the client's own [synthesis].

B8. Adjustment, identity and personality change

Purpose: the guideline notes personality change is not automatically a problem and may even be a goal, but all changes must be recorded, and social readjustment needs ongoing support [source: Nuttin 2014].
Steps: (1) Make room for the person's experience of being changed: relief, grief for lost years, unfamiliar free time, relationship shifts, stigma about "brain surgery". (2) Help rebuild routines, roles, work and leisure in steps, involving occupational or vocational rehabilitation where the team offers it [source: Nuttin 2014 lists rehabilitation specialists and vocational trainers; synthesis]. (3) If the outcome is poor, support grief and renewed hope without blame [synthesis].
Example language (illustrative): "After so many years organised around the OCD, it can feel strange to have time back. What would you like to fill it with?"
Watch for: shame, a sense of being "not myself", or a family describing someone new [synthesis].

B9. Integrating CBT/ERP and other psychotherapy after surgery

Purpose: to make use of any symptom reduction. Miguel et al. suggest improvement may partly reflect better response to medication and psychological therapy acting together with surgery [source: Miguel 2019]. No published protocol for post-operative ERP is described in the sources [uncertain].
Steps [synthesis]: (1) Agree timing with the surgical team (usually after early recovery). (2) Re-assess OCD with the measures used at baseline. (3) Rebuild an exposure hierarchy and start ERP at a manageable level; people who could not tolerate it before may manage it now. (4) For depression, use behavioural activation and relapse-prevention work. (5) Address apathy or initiative problems with structured scheduling rather than interpreting them as resistance, and report them. (6) Work on family accommodation and relapse prevention. (7) Share progress with the team.
Example language (illustrative): "The operation may have turned the volume down. Exposure work is how we teach your brain that the alarm is false."
Watch for: disinhibition affecting exposure choices; mood disturbance; no change at all, which needs passing back to the team [synthesis].

B10. Conversations about medicines and follow-up

Purpose: medication is still needed alongside surgery [source: Whitehead & Barrera 2023]; you support adherence discussions without advising changes [synthesis].
Steps: (1) Ask openly about doubts over medicines or follow-up visits. (2) Explore ambivalence with motivational questions. (3) Route all medicine questions to the prescriber; never suggest stopping or changing. (4) Encourage keeping long-term neurological and neuropsychological appointments [source: Nuttin 2014 on 5-10 year follow-up].
Example language (illustrative): "It sounds like you're wondering whether you still need the tablets now. That's a really good question to take to your psychiatrist; shall we write it down?"
Watch for: stopping medicines unilaterally after improvement; missing follow-up [synthesis].

B11. Long-term support, ending and handover

Purpose: non-abandonment until care is formally transferred [source: Nuttin 2014].
Steps: (1) Taper sessions only when gains are stable and a relapse plan is written. (2) Confirm who now holds follow-up responsibility. (3) Hand over in writing if you leave the service. (4) Offer booster sessions [synthesis].
Example language (illustrative): "Before we finish, let's make sure you know who's following you up and what to do if things slip."
Watch for: dropping out of follow-up years later [synthesis].

5. Handling problems

The sources say little about psychotherapy problems around NMD; most of this section is [synthesis], with sourced points marked.

Client fixated on surgery as the only answer, avoiding exposure work. Acknowledge the exhaustion; name that adequate ERP is part of what any panel will look for [source: Nuttin 2014; Copetti 2020 inclusion criteria]; offer an intensive or specialist ERP option as a step that keeps all doors open [synthesis].
Stuck in ambivalence for months. Use a written decision balance and separate "deciding to be assessed" from "deciding to have surgery"; assessment commits to nothing [synthesis].
Desperation or a suicidal crisis during the process. The guideline warns desperation drives hasty decisions [source: Nuttin 2014]. Prioritise safety (B6), inform the team; a decision made in crisis should not be presented to a panel as settled consent [synthesis].
Rupture: the client feels you are against (or for) surgery. Restate your role: you support their decision-making and their recovery either way; invite them to tell you when you seem to lean [synthesis].
Family pressure or conflict. See the client alone; say openly that only the person's own consent counts in most frameworks (Victoria explicitly bars substitute consent; Scotland bars treating an objecting incapable person) [source: Health Victoria; MH(CT)(S)A 2003 notes]; raise concerns about coercion with the team [synthesis].
Panel refusal or legal certificate refused. Expect grief and anger; review safety; help the person ask what would change the decision, and return to the best available standard care [synthesis].
Overwhelm after surgery (sudden change, too much free time, relationship shifts). Slow the pace; structure the week; involve rehabilitation and family sessions [source: Nuttin 2014 on readjustment support; steps synthesis].
Apathy, low initiative or disinhibition (modality-specific). Do not treat these as resistance or non-adherence; record and report to the team (reported effects of capsulotomy and gamma knife) [source: Mavridis & Pyrgelis 2025; Whitehead & Barrera 2023]. Adapt therapy: shorter tasks, external prompts, carer support, clear boundaries [synthesis].
Non-adherence to post-operative ERP or medicines. Explore reasons (fear, "the operation should have fixed it", apathy); motivational work; medicine questions go to the prescriber [synthesis].
Disappointing or slow response. Remind the person that response can arrive late (6-36 months in gamma capsulotomy series) and that some do not respond [source: Miguel 2019]; keep measuring, keep therapy going, and pass findings on [synthesis].
Worsening symptoms or new neurological signs. Pass on promptly; urgent signs to urgent care; gamma-knife complications can appear years later [source: Mavridis & Pyrgelis 2025].
Your own reactions (horror linked to lobotomy, or rescue fantasies). Take them to supervision; the modern procedure is regulated very differently, but the history explains why scrutiny matters (see Harm account) [synthesis].
Confidentiality with the surgical team. Agree at the start, in writing, what you will share and how [synthesis].
Client seeking surgery abroad or privately without a recognised panel. Explain which safeguards the consensus guideline and local law require and encourage discussion with their psychiatrist before any travel [source: Nuttin 2014; synthesis].

Harm account

Short, attributed summary. The full historical harm account of lobotomy is in Domain XVI.

What was actually done

Early psychosurgery: Gottlieb Burckhardt performed the first brain operations for mental illness in the late 1880s; among his first patients one died and one later died by suicide [source: eb.com].
1935-36, Lisbon: after John Fulton's 1935 London presentation on frontal-lobe removal in chimpanzees, neurologist Egas Moniz, with neurosurgeon Almeida Lima, operated on about twenty patients within a year ("leucotomy"), first destroying frontal tissue chemically and later cutting it with an instrument, and reported benefit mainly in schizophrenia and depression [source: Torkildsen 2022]. Moniz received the 1949 Nobel Prize in Physiology or Medicine, which Torkildsen calls a stain on the Prize's history [source: Torkildsen 2022].
United States: Walter Freeman and James Watts developed a standard prefrontal lobotomy; by 1942 they had operated on more than 200 patients, reporting 63% improved, 24% unchanged and 14% worse [source: Torkildsen 2022]. From 1946 Freeman promoted a quicker "transorbital" operation through the eye socket; Watts ended their partnership over it in 1947 [source: Torkildsen 2022]. Freeman performed about 3,439 lobotomies with a reported 14% mortality [source: Torkildsen 2022]; another account says over 3,500, perhaps 490 fatal [source: eb.com] - figures differ [uncertain].
Scale: more than 5,000 operations in the US in 1949 alone [source: Torkildsen 2022]; more than 50,000 in the US overall, mostly 1949-1952; more than 4,500 in Sweden 1944-1966; about 3,000 in Norway 1940-1960 [source: eb.com; Torkildsen 2022].
Who and how: patients included children, women and severely ill, often institutionalised people; in Sweden most patients were women; parents, husbands and doctors could arrange the operation without the patient's consent or knowledge, and some patients never learned they had been operated on [source: eb.com]. Howard Dully was 12 when his stepmother arranged his lobotomy, and learned of it decades later [source: eb.com, citing NPR]. Rosemary Kennedy was operated on in 1941 [source: Torkildsen 2022].

How it caused harm

Destruction of frontal brain tissue left many patients apathetic and passive, with loss of initiative, concentration and emotional responsiveness; some were left with childlike functioning; Rosemary Kennedy needed lifelong care [source: Torkildsen 2022; eb.com].
Deaths from the operation (see figures above) [source: Torkildsen 2022; eb.com].
Psychological sequelae: Dully later described shame and feeling like a freak [source: eb.com].
Systemic mechanisms: enthusiasm outran evidence; a charismatic promoter with media access, prestige (including the Nobel Prize) and pioneers' reports that underplayed adverse effects drove rapid spread; a 1959 Norwegian editorial called the practice "random, indiscriminate and lacking in neurophysiological and neuroanatomical insight" [source: Torkildsen 2022]. Absence of consent and use on people without power (children, women, institutionalised patients) made the harm possible [source: eb.com].
Decline: criticism grew in the 1940s-50s; the Soviet Union banned lobotomy in 1950 as inhumane; neuroleptic (antipsychotic) drugs arrived in the 1950s [source: Torkildsen 2022]. Norway later compensated people who had been lobotomised (a news item with that title is indexed in PubMed) [uncertain].

Recognising it today

[Synthesis based on the safeguards in Nuttin 2014 and the legal sources, and on Torkildsen's lessons.]

Surgery proposed to control behaviour, aggression or "manageability", or for social, legal or institutional convenience, rather than to relieve the person's own suffering [source: Nuttin 2014].
Consent given by someone else for a person who objects, cannot understand, or is a child, outside a court or tribunal process; or the person not told fully [source: Nuttin 2014; MH(CT)(S)A 2003; Health Victoria; San Mateo policy on minors].
One clinician deciding alone; no independent psychiatric assessment, neuropsychological evaluation, ethics review or statutory second opinion [source: Nuttin 2014; MHA 1983 s57].
Surgery offered before adequate standard treatment, or for conditions with only case-report evidence, presented as established [source: Nuttin 2014; Mavridis & Pyrgelis 2025].
Marketing language promising cure, quick fixes or minimised risks; undisclosed financial interests; no long-term follow-up or reporting of failures [source: Nuttin 2014; Torkildsen 2022 on charismatic promotion].
How legitimate practice differs: last resort for severe refractory OCD or depression, unanimous multidisciplinary decision, the person's own sustained consent, independent certification, honest outcome reporting and years of follow-up [source: Nuttin 2014; legal sources].

What to do instead and how to help those harmed

Instead: expert standard care first (adequate medicines, CBT/ERP, ECT where indicated); if truly refractory, assessment at a recognised specialist centre under the legal safeguards in A2; reversible options such as DBS within research oversight [source: Nuttin 2014; Whitehead & Barrera 2023].
Survivors and families [synthesis]: a few older people, and many families, carry the legacy of historical lobotomy or poorly regulated surgery. Believe and validate; ask what they know and want to know; help request medical records; with consent refer for neurological and neuropsychological assessment and for rehabilitation; support grief, anger and shame in relatives who arranged or could not stop an operation; signpost to information about any national redress scheme [uncertain: none verified beyond the Norway item].
Duties [synthesis]: if you learn of current surgery without valid consent or the required certification, or on a child where law prohibits it, raise it through safeguarding procedures and the relevant regulator or mental health commission (e.g. the body that appoints s57 doctors in England and Wales, the Mental Welfare Commission in Scotland, the Chief Psychiatrist or Mental Health Tribunal in Victoria), and consult your professional body and supervisor [regulator names from the legal sources; reporting route synthesis].

Sources

Sources:

Further reading (not drawn on) [uncertain]: California W&I Code 5326.6 statute text; Welsh Government Form CO 1 (s57 certificate); PubMed news item "Norway compensates lobotomy victims"; "Cognitive Behavioral Therapy Versus Psychosurgery for Refractory Obsessive-Compulsive Disorder", J Neuropsychiatry Clin Neurosci 18(1):129.

← Previous · IX-028Focused ultrasound (MRgFUS thalamotomy, capsulotomy, low-intensity)Next · IX-030 →Stellate ganglion block